Home › Free Stock Grades › EBS
Emergent BioSolutions Inc. (EBS) Stock Grade
EBS · Healthcare
B-
Market Cap
$661.3M
P/E Ratio
12.6
Revenue Growth (YoY)
-28.8%
Net Margin
7.1%
Return on Equity
10.1%
Dividend Yield
None
About Emergent BioSolutions Inc.'s fundamentals
Emergent BioSolutions is a biotechnology company with a market capitalization of $661.3 million, currently trading at a P/E ratio of 12.6. The company is experiencing significant headwinds, with revenue declining 28.8% year-over-year, though it maintains profitability with a net margin of 7.1% and generates a 10.1% return on equity. The company does not pay a dividend, suggesting it may be reinvesting earnings or preserving cash during this period of revenue contraction.